Afortunadamente, las mculas melanticas son inofensivas
For example, critical issues such as optimal timing, dose adjustment, and drugdrug interactions when combining GLP-1RAs with traditional AF treatments or other cardiovascular drugs require further large-scale clinical studies to be established
Clinical trials show 24.2% weight loss with Retatrutide
Despite this, fewer than 1 in 5 employers with over 200 employees currently cover GLP1s for weight loss purposes, even as employee interest continues to climb steadily
For some people who are particularly vulnerable to sarcopenia, it is important to be cautious when using GLP-1s to avoid too much loss of muscle mass
In terms of how this merger will effect early-investments in the space, more funds will focus on and invest in digital health